Matrixx Says May Issue Zicam Recall
Matrixx, replying to FDA's Zicam warning says FDA's action is "unwarranted," and thinks Zicam products are safe and "do not cause anosmia," but may issue a Zicam recall after determining it's response to FDA.
Earlier FDA had told consumers to stop using three products marketed over-the-counter as cold remedies because they are associated with the loss of sense of smell (anosmia). Anosmia may be long-lasting or permanent.
No Zicam reall from Matrixx yet, but the company is considering its response.
Matrixx released the following on Zicam today.
"The Company believes these products are safe and do not cause anosmia. The Company's position is supported by the cumulative science and has been confirmed by a multi-disciplinary panel of scientists. (See the Company's Report on Form 10-K under the heading "Legal Proceedings - Product Liability Matters" for additional information.)
"The Company believes the FDA action is unwarranted and is in the process of determining its response, which may include removing these products from the marketplace. These products constituted approximately 40% of the Company's net sales in 2009."
We will inform our reader if Matrixx issues Zicam recall.